rs,
07PLC051093 October 17, 2025 To, The Listing Department, BSE LIMITED, Phiroze Jeejeebhoy Towers, Dalal Street, Fort Mumbai- 400 001 To, The Listing Department National Stock Exchange of India
₹3,062
s. This disciplined approach is now yielding tangible results as we (Mn.) Revenue for Q2 FY26 ₹3,062 YoY 24.1% strengthen global partnerships and expand into new growth EBIDTA for Q2 FY26 verticals
24.1%
ciplined approach is now yielding tangible results as we (Mn.) Revenue for Q2 FY26 ₹3,062 YoY 24.1% strengthen global partnerships and expand into new growth EBIDTA for Q2 FY26 verticals such as
₹3,062
million
uch as Battery Chemicals and Semiconductors. In Q2 FY26, our revenue grew by 24.1% year-on-year to ₹3,062 million, driven by strong performance in Advanced Pharmaceutical Intermediates and stable contributions f
25%
iates and stable contributions from Specialty Chemicals. We remain confident of delivering around 25% revenue growth for the full year, backed by a resilient business foundation and clear strategic
₹953
th for the full year, backed by a resilient business foundation and clear strategic direction” ₹953 YoY 94.8% PAT for Q2 FY26 ₹719 YoY 91.3% Earnings Presentation | October 2025 2 Q2 FY26 Financ
94.8%
e full year, backed by a resilient business foundation and clear strategic direction” ₹953 YoY 94.8% PAT for Q2 FY26 ₹719 YoY 91.3% Earnings Presentation | October 2025 2 Q2 FY26 Financial Perfo
₹719
resilient business foundation and clear strategic direction” ₹953 YoY 94.8% PAT for Q2 FY26 ₹719 YoY 91.3% Earnings Presentation | October 2025 2 Q2 FY26 Financial Performance – Key Metrics Rev
91.3%
business foundation and clear strategic direction” ₹953 YoY 94.8% PAT for Q2 FY26 ₹719 YoY 91.3% Earnings Presentation | October 2025 2 Q2 FY26 Financial Performance – Key Metrics Revenue from
27.4%
October 2025 2 Q2 FY26 Financial Performance – Key Metrics Revenue from Operations YoY Growth 27.4% 7.3% 2,626 2,061 24.1% 3,062 2,467 407 436 Advance Intermediates Specialty Chemicals Tot
7.3%
r 2025 2 Q2 FY26 Financial Performance – Key Metrics Revenue from Operations YoY Growth 27.4% 7.3% 2,626 2,061 24.1% 3,062 2,467 407 436 Advance Intermediates Specialty Chemicals Total Q2
19.8%
nce Intermediates Specialty Chemicals Total Q2FY25 Q2FY26 EBITDA & EBITDA Margin (₹ Mn) PAT 19.8% 489 Q2FY25 31.1% 953 Q2FY26 (₹ Mn.) 23.5% 719 Q2FY26 15.2% 376 Q2FY25 EBITDA EBITDA M